APA (7th ed.) Citation

D, B., D, S., T, K., BA, D., AJ, J., & G, L. (2025). Distinguishing Daratumumab from Endogenous Monoclonal Proteins in Serum from Multiple Myeloma Patients Using an Automated Mass Spectrometry System. The journal of applied laboratory medicine, 10(2), 235. https://doi.org/10.1093/jalm/jfae142

Chicago Style (17th ed.) Citation

D, Barnidge, Sakrikar D, Kubicki T, Derman BA, Jakubowiak AJ, and Lakos G. "Distinguishing Daratumumab from Endogenous Monoclonal Proteins in Serum from Multiple Myeloma Patients Using an Automated Mass Spectrometry System." The Journal of Applied Laboratory Medicine 10, no. 2 (2025): 235. https://doi.org/10.1093/jalm/jfae142.

MLA (9th ed.) Citation

D, Barnidge, et al. "Distinguishing Daratumumab from Endogenous Monoclonal Proteins in Serum from Multiple Myeloma Patients Using an Automated Mass Spectrometry System." The Journal of Applied Laboratory Medicine, vol. 10, no. 2, 2025, p. 235, https://doi.org/10.1093/jalm/jfae142.